CVS Nov 2024 62.500 call
| Previous close | 3.9500 |
| Open | 4.2300 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 62.50 |
| Expiry date | 2024-11-15 |
| Day's range | 3.9500 - 4.3600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksIs CVS Health (CVS) a Buy as Wall Street Analysts Look Optimistic?
According to the average brokerage recommendation (ABR), one should invest in CVS Health (CVS). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks2 Stocks to Watch & One to Avoid From the Volatile Retail Pharmacy Industry
Zacks Retail-Pharmacies and Drug Stores industry players like WBA and HLF are likely to gain despite reimbursement challenges that are hurting the overall health of the industry. CVS might struggle in the face of economic challenges.
Associated Press FinanceAs pharmacies shutter, some Western states, Black and Latino communities are left behind
Opening stores used to mean everything to pharmacy chains. CVS Health once boasted of opening or buying more than 2,900 locations in a five-year period. Now it’s shuttering hundreds, while Walgreens, Rite Aid and independent drugstores also pull back.
